TP53 and Treacher-Collins syndrome: Keeping in mind that pathogenic mechanisms involved in Treacher Collins syndrome are dependent on the Tp53 pathway4, our in vivo ATRA-treatment results show similar processes where ATRA-exposure led to an increase of apoptosis processes at late time points and thus could participate in producing the developmental defects observed.